CD36-TSP-HRGP Interactions in the Regulation of Angiogenesis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|35|3559-3567

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.35, 2007-12, pp. : 3559-3567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Harnessing CD36 to Rein in Inflammation

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 3, 2008-09 ,pp. : 184-191

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Angiogenesis by the Kallikrein-Kinin System

By  

Current Pharmaceutical Design, Vol. 12, Iss. 21, 2006-07 ,pp. : 2599-2607

Bentham Science Publishers

Access to resources Recommend Favorite

The Renin Angiotensin System in the Regulation of Angiogenesis

By  

Current Pharmaceutical Design, Vol. 13, Iss. 12, 2007-04 ,pp. : 1215-1229

Bentham Science Publishers

Access to resources Recommend Favorite

CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke

By  

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3721-3730

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Angiogenesis and Angiogenic Factors by Cardiovascular Medications

By  

Current Pharmaceutical Design, Vol. 13, Iss. 20, 2007-07 ,pp. : 2113-2117

Bentham Science Publishers

Access to resources Recommend Favorite